Risk factors for mortality in ICU patients with Acinetobacter baumannii ventilator-associated pneumonia: impact of bacterial cytotoxicity.
暂无分享,去创建一个
Dongni Hou | Yuanlin Song | Jie Liu | Xinjun Tang | Cuicui Chen | Huayin Li | S. Chen | Mohan Ju | Ying Wang
[1] A. Zlotnik,et al. Multidrug Resistance Acinetobacter Bacteremia Secondary to Ventilator-Associated Pneumonia: Risk Factors and Outcome , 2017, Journal of intensive care medicine.
[2] Evangelos I. Kritsotakis,et al. Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients. , 2016, International journal of antimicrobial agents.
[3] L. Martínez-Martínez,et al. Acinetobacter baumannii and A. pittii clinical isolates lack adherence and cytotoxicity to lung epithelial cells in vitro. , 2016, Microbes and infection.
[4] I. Cinel,et al. Vitamin D level is associated with mortality predictors in ventilator-associated pneumonia caused by Acinetobacter baumannii. , 2016, Journal of infection in developing countries.
[5] Y. Geffen,et al. Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin–Sulbactam , 2016, American journal of therapeutics.
[6] Yi Xie,et al. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China , 2015, PloS one.
[7] Cary L. Honnold,et al. Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] C. Bumroongkit,et al. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia , 2015, Journal of Intensive Care.
[9] P. Kaur,et al. Incidence and attributable costs of ventilator-associated pneumonia (VAP) in a tertiary-level intensive care unit (ICU) in northern India. , 2015, Journal of infection and public health.
[10] N. P. H. Lan,et al. Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam , 2014, Journal of medical microbiology.
[11] Xiaochun Song,et al. Differences in incidence and outcome of ventilator‐associated pneumonia in surgical and medical ICUs in a tertiary hospital in China , 2014, The clinical respiratory journal.
[12] C. Bai,et al. PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury , 2014, Respiratory Physiology & Neurobiology.
[13] A. Kaya,et al. Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes. , 2014, American journal of infection control.
[14] A. Akin,et al. Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia , 2014, Infection.
[15] Qi Zhou,et al. Efficacy of an infection control program in reducing ventilator-associated pneumonia in a Chinese neonatal intensive care unit. , 2013, American journal of infection control.
[16] N. Shime,et al. Evaluation of semi-quantitative scoring of Gram staining or semi-quantitative culture for the diagnosis of ventilator-associated pneumonia: a retrospective comparison with quantitative culture , 2013, Journal of Intensive Care.
[17] Tae Hyong Kim,et al. Risk Factors for Mortality in Patients with Acinetobacter baumannii Bacteremia , 2013, Infection & chemotherapy.
[18] Y. Arabi,et al. Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[19] Jian-hui Chen,et al. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. , 2013, American journal of infection control.
[20] Y. Lei,et al. Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia. , 2013, The American journal of medicine.
[21] M. Adams,et al. Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis , 2012, mBio.
[22] S. Kuo,et al. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia. , 2012, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[23] Yi-Tsung Lin,et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] Sang Il Kim,et al. Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy , 2012, Journal of Korean medical science.
[25] M. Kollef,et al. Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort , 2012, Infection Control & Hospital Epidemiology.
[26] Eric Déziel,et al. MexEF-OprN Efflux Pump Exports the Pseudomonas Quinolone Signal (PQS) Precursor HHQ (4-hydroxy-2-heptylquinoline) , 2011, PloS one.
[27] M. Surette,et al. Inactivation of MuxABC-OpmB transporter system in Pseudomonas aeruginosa leads to increased ampicillin and carbenicillin resistance and decreased virulence , 2011, The Journal of Microbiology.
[28] J. Rello,et al. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study , 2011, Critical care.
[29] J. Vila,et al. Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species , 2011, BMC Research Notes.
[30] W. Ko,et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[31] B. Sumerkan,et al. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. , 2009, European journal of internal medicine.
[32] D. Moranta,et al. Klebsiella pneumoniae triggers a cytotoxic effect on airway epithelial cells , 2009, BMC Microbiology.
[33] Chul Hee Choi,et al. Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity , 2007, Cellular microbiology.
[34] A. MacGowan,et al. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.